Klebsiella pneumoniae is one of the most common and most dangerous bacterial pathogens impacting humans, causing infections of the gastrointestinal tract, pneumonia, wound infections and even blood poisoning. With the aim of discovering therapeutically exploitable weaknesses in Klebsiella, a research team from the Balance of the Microverse Cluster of Excellence at the University of Jena, Germany has taken a close look at the molecular biology of the bacteria and was able to uncover the importance of a small, non-coding ribonucleic acid (sRNA for short) for the gene regulation of K. pneumoniae. They report their findings in the journal “Proceedings of the National Academy of Sciences”.